Mizuho Maintains Buy on Staar Surgical, Raises Price Target to $53
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone has maintained a Buy rating on Staar Surgical (NASDAQ:STAA) and increased the price target from $45 to $53.
April 11, 2024 | 11:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho has reaffirmed its Buy rating on Staar Surgical and raised the price target from $45 to $53.
The upgrade in price target by a reputable analyst like Anthony Petrone suggests a strong confidence in Staar Surgical's future performance. This is likely to positively influence investor sentiment and could lead to an increase in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100